David Humphrey
2022
In 2022, David Humphrey earned a total compensation of $780.6K as Chief Financial Officer at Ensysce Biosciences, a 175% increase compared to previous year.
Compensation breakdown
| Option Awards | $438,562 |
|---|---|
| Salary | $328,333 |
| Other | $13,722 |
| Total | $780,617 |
Humphrey received $438.6K in option awards, accounting for 56% of the total pay in 2022.
Humphrey also received $328.3K in salary and $13.7K in other compensation.
Rankings
In 2022, David Humphrey's compensation ranked 3,516th out of 5,625 executives tracked by ExecPay. In other words, Humphrey earned more than 37.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,516 out of 5,625 | 38th |
Division Manufacturing | 1,991 out of 3,053 | 35th |
Major group Chemicals And Allied Products | 945 out of 1,380 | 32nd |
Industry group Drugs | 883 out of 1,281 | 31st |
Industry Pharmaceutical Preparations | 640 out of 927 | 31st |
Source: SEC filing on July 13, 2023.
Humphrey's colleagues
We found two more compensation records of executives who worked with David Humphrey at Ensysce Biosciences in 2022.